Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Postmarket Study for Continuing Evaluation and Periodic Reporting of the Safety and Effectiveness of the Spatz3 Intragastric Balloon

NCT05086302 is registered in ClinicalTrials.gov with Spatz FGIA, Inc as lead sponsor.

NCT NCT05086302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05086302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Postmarket Study for Continuing Evaluation and Periodic Reporting of the Safety and Effectiveness of the Spatz3 Intragastric Balloon
Lead sponsor
Spatz FGIA, Inc
Phase
Observational
Overall status
Completed
Start date
December 3, 2021
Completion date
January 13, 2025
Enrollment
537 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

obesity